Some 330 jobs hit as Novartis closes Morphosys, WiWo reports
BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
Related
A top recruiter says sports marketing roles are hot right…
Jobs are opening up in the sports industry as teams expand and money flows into the industry.Excel Search &
Public employees and the private job market: Where will fired…
Fired federal workers are looking at what their futures hold. One question that's come up: Can they find similar salaries and benefits in the private sector?
Mortgage and refinance rates today, March 8, 2025: Rates fall…
After two days of increases, mortgage rates are back down again today. According to Zillow, the average 30-year fixed rate has decreased by four basis points t
U.S. economy adds jobs as federal layoffs and rising unemployment…
Julia Coronado: I think it's too early to say that the U.S. is heading to a recession. Certainly, we have seen the U.S. just continue t
